A diagnosis of lung cancer can be overwhelming for the entire family. Open discussion between family members, health professionals and patients can help ensure the best care. In this "Ask the Expert" series, leading lung cancer experts answer questions about new treatments, research and clinical trials related to lung cancer.
Stay on top of lung cancer biopsy information with Drs. Ross Camidge and Nisha Mohindra.
Published:
Will the U.S. be utilizing the lung cancer vaccine, CimaVax, that is used in Cuba? Dr. Ross Camidge reports CimaVax’s progress.
Published:
Dr. Ross Camidge answers a question about biomarker tests as part of lung cancer diagnosis.
Published:
What are liquid biopsies and would they be useful in my diagnosis and treatment?
Published:
New lung cancer treatment? Learn about expected and unexpected side effects. Janet Daily-Freeman interviews Dr. Ross Camidge.
Published:
Your Submitted Questions Answered
Q&A: Immunotherapy and Future Options in Lung Cancer
Q&A: Can Targeted Therapies and Immunotherapies Treating Lung Cancer Stop Working?
Q&A: Is Joint Pain a Side Effect of Immunotherapy in Lung Cancer?
Q&A: Can Cannabinoids Be Added to Lung Cancer Treatment Programs?
Q&A: Why Aren't Lung Cancer Patients Invited to Participate on Tumor Boards?
Q&A: Will I Need Multiple Biopsies?
Q&A: If Chemotherapy Is Working, Should I Also Be Considering Immunotherapy?
Q&A: Is There Benefit to Genetic Testing in Earlier Stages of Lung Cancer?
Q&A: Are There Benefits to Lung Cancer Patients in Using Supplements?
This Ask the Expert series is sponsored by Merck.
